A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer Review uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Receptors, Vascular Endothelial Growth Factor
  • TOR Serine-Threonine Kinases
  • Vascular Endothelial Growth Factor A

abstract

  • We thoroughly examined the literature on the benefits and harms of combining drugs for the treatment of kidney cancer that has spread and on the sequence in which the drugs should be given.

publication date

  • January 2015

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2014.04.006

PubMed ID

  • 24841777

Additional Document Info

start page

  • 100

end page

  • 10

volume

  • 67

number

  • 1